KING OF PRUSSIA, Pa., March 06, 2017 -- CardConnect (NASDAQ:CCN), a leading provider of payment processing and technology solutions, today announced that the Company will be attending the Barclays 7th Annual Emerging Payments Forum. The conference will be held at the Intercontinental New York Times Square Hotel on March 14-15, 2017. Chief Executive Officer and President Jeff Shanahan will be part of a special panel taking place on Tuesday, March 14, at 1:30 p.m. ET. The panel topic will be on Point of Sale (POS) differentiation.
This special panel event will not be webcast. To schedule a meeting with Mr. Shanahan please contact your Barclays representative.
About CardConnect
CardConnect (NASDAQ:CCN) is a leading provider of payment processing and technology solutions, helping more than 67,000 organizations – from independent coffee shops to iconic global brands – accept billions of dollars in card transactions each year. Since its inception in 2006, CardConnect has developed advanced payment solutions backed by patented, PCI-validated point-to-point encryption (P2PE) and tokenization. The company’s small-to-midsize business offering, CardPointe, is a comprehensive platform that includes a powerful reporting and transaction management portal which extends to a native mobile app. For enterprise-level organizations, CardSecure integrates omni-channel payment acceptance into several ERP systems – such as Oracle, SAP, JD Edwards and Infor M3 – in a way that minimizes PCI compliance requirements and lowers transaction costs.
Contact: Joe Hassett Gregory FCA 610-228-2110 [email protected]


Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 



